Descemetorhexis Without Endothelial Keratoplasty (DWEK)
This study evaluates the possibility of removing a section of Descemet’s membrane along with its diseased endothelial cells, without corneal transplantation, and simply leaving the cornea to heal on its own, as a new treatment for Fuchs’ Endothelial Dystrophy (FED). This procedure is known as ‘Descemetorhexis Without Endothelial Keratoplasty (DWEK)’ or ‘Descemet’s stripping only (DSO)’. DWEK/DSO may improve vision in persons with FED without the need for traditional corneal transplantation.
Keratoconus International Consortium (KIC)
International collaborative study to evaluate Keratoconus.
RMH Ophthalmology Clinical Trials
IONIS: A Phase 2, randomised, placebo-controlled, double-masked study to assess safety and efficacy of multiple doses of IONIS-FB-LRX, an antisense inhibitor of Complement Factor B, in patients with Geographic Atrophy secondary to Age-Related Macular Degeneration (AMD).
View Dr Elaine Chong's latest PubMed publications here